HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Apolipoprotein B Familial Hypobetalipoproteinemia

An autosomal dominant disorder of lipid metabolism. It is caused by mutations of APOLIPOPROTEINS B, main components of CHYLOMICRONS and BETA-LIPOPROTEINS (low density lipoproteins or LDL). Features include abnormally low LDL, normal triglyceride level, and dietary fat malabsorption.
Also Known As:
Hypobetalipoproteinemia, Familial, Apolipoprotein B; Abetalipoproteinemia, Normotriglyceridemic, Steinbert Type; Apolipoprotein B Deficiency Disease; Hypobetalipoproteinemia, Familial, Apo B; Apolipoprotein B Deficiencies; Apolipoprotein B Deficiency
Networked: 7 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Related Diseases

1. Fatty Liver

Experts

1. Desai, H G: 2 articles (01/2003 - 02/2001)
2. Albrecht, C: 1 article (04/2016)
3. Bruckmaier, R M: 1 article (04/2016)
4. Drögemüller, C: 1 article (04/2016)
5. Gross, J J: 1 article (04/2016)
6. Menzi, F: 1 article (04/2016)
7. Schmitz-Hsu, F: 1 article (04/2016)
8. Schwinn, A-C: 1 article (04/2016)
9. Artekar, T M: 1 article (01/2003)
10. Shah, S S: 1 article (02/2001)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Apolipoprotein B Familial Hypobetalipoproteinemia:
1. LipidsIBA
2. Transaminases (Aminotransferases)IBA
3. CholesterolIBA
4. SteroidsIBA
5. LDL CholesterolIBA
6. ChylomicronsIBA
7. ApolipoproteinsIBA